New York’s progress in combating the coronavirus pandemic has stalled in recent weeks, leaving the state with the highest COVID-19 hospitalization rate and second-highest infection rate in the U.S.

The number of newly diagnosed cases per day has been virtually flat since mid-February at just under 40 per 100,000 residents, which is roughly double the national average and second only to New Jersey.

New York’s hospitalizations have been declining, but more slowly than in the country as a whole. Its rate as of March 7 was 246 per million, which was also double the national average.

The state’s current death rate of .48 per 100,000 is roughly in line with the U.S. norm, and is going down. Because mortality is a lagging indicator, that trend is likely to level off if current patterns don’t change.

New York returned to being a national hotspot during the winter wave, when its infection rate increased faster, peaked later and dropped more slowly than that of the country as a whole.

The infection rate declined sharply after the New Year, but leveled off in mid-February. The reasons are unclear, but could include an erosion of compliance with social distancing rules or the advent of coronavirus variants that are more infectious.

Around the same time New York’s progress stalled, Governor Cuomo was hit with a series of scandals over his handling of nursing home data and allegations of bullying behavior and sexual harassment

Cuomo’s briefings on the pandemic, which have been less frequent, have accentuated positive news. He has not highlighted New York’s worst-in-the-nation hospitalization rate, and he has continued rolling back coronavirus-related restrictions, albeit more slowly than in some other states.

New York’s high infection rate might in part reflect its higher level of testing, which would identify more mild or asymptomatic cases. That would not affect its hospitalization rate, which is back to its level of mid-May 2020.

In another echo of last spring, the pandemic is once again most severe in the New York City area, including Long Island and the lower Hudson Valley.

 

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

The Attorney General’s MFCU SNAFU

Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office. On T Read More

Healthcare Revelations in the Enacted Budget Financial Plan

The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before. Read More

Federal Suit Traces Medicaid Fraud to the Top of NYS Government

The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor. A Read More

Healthcare Highlights in the New State Budget

Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget. The deal finalized May 27 Read More

Lawmakers Consider Hiking Fees for Filling Prescriptions

UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More

Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax

As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations. Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More